NCT03591445

Brief Summary

This study is one of Eastern Cooperative Thoracic Oncology Projects (ECTOP-1005). It aims to evaluate the role of flexible bronchoscopy in the pre-operative workup of ground glass opacity featured lung cancer. All enrolled patients receive the flexible bronchoscopy examination before surgery. Investigators observe the intra-bronchial findings of bronchoscopy and the impact of these findings on established surgical plan.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
615

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 7, 2018

Completed
12 days until next milestone

First Posted

Study publicly available on registry

July 19, 2018

Completed
4 months until next milestone

Study Start

First participant enrolled

November 6, 2018

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2019

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2020

Completed
Last Updated

July 20, 2023

Status Verified

July 1, 2023

Enrollment Period

1.1 years

First QC Date

July 7, 2018

Last Update Submit

July 18, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Incidence rate that established surgical plan is changed by positive intra-bronchial findings

    The number of patients (surgical plan is changed by positive intra-bronchial findings) /Total number of patients

    about 14 days

Secondary Outcomes (1)

  • rate of positive intra-bronchial findings

    about 14 days

Study Arms (1)

Experimental:Bronchoscopy

EXPERIMENTAL

Patients with ground glass opacity featured lung cancer who are candidates for surgeyr received the bronchoscopy examination before surgery.

Device: Flexible Bronchoscopy

Interventions

Flexible Bronchoscopy

Experimental:Bronchoscopy

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Ground glass opacity pulmonary nodule diagnosed by thoracic CT
  • karnofsky performance status ≥60
  • No surgical contraindication
  • Patients who sign the informed consent
  • Pre-operation clinical stage :T1abcN0M0
  • Age:18-80 years old

You may not qualify if:

  • Central lung tumor diagnosed by CT
  • Tracheal or bronchus deformity diagnosed by CT
  • Tracheal or bronchus disease history
  • Severe smoking history (smoking index ≥400/year)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fudan University Shanghai Cancer Center

Shanghai, China

Location

MeSH Terms

Conditions

Solitary Pulmonary Nodule

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: We hypothesized incidence rate that bronchoscopic findings would have changed the rate of established surgical plans as less than 2.0% (P0), then preoperative bronchoscopy examination would have limited impact on the surgical plan for GGO featured lung cancer; If bronchoscopic findings would have changed the rate of established surgical plans as more than 4.0% (P1), then bronchoscopy examination would be regarded as one routine preoperative work-up. Null hypothesis: H0: P≤P0; Alternative hypothesis: HA: P ≥ P1. α = 0.05, 1-β = 0.9. Using Simon's two-stage approach, the first phase enrolled 612 patients. If ≥18 patients supported the alternative hypothesis, they entered the second phase, otherwise the trial was terminated; the second phase enrolled 451 patients. If the patient number who eventually changes the surgical plan is ≤27, the null hypothesis is accepted, that preoperative bronchoscopy examination would be unnecessary for GGO featured lung cancer.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Department of thoracic surgery and multidisciplinary group of thoracic oncology

Study Record Dates

First Submitted

July 7, 2018

First Posted

July 19, 2018

Study Start

November 6, 2018

Primary Completion

November 30, 2019

Study Completion

June 30, 2020

Last Updated

July 20, 2023

Record last verified: 2023-07

Locations